Dana Yaacov-Garbeli

Dana Yaacov-Garbeli

Chief Finance OfficeratEntera Bio· In proxies 2022–2024

Pay in FY2023-18% from the year before · Entera Bio stock -17.8% the same year

Dana Yaacov-Garbeli was paid $311 in FY2023 (Dec), down 18%. Entera Bio stock fell 17.8% that year.

Pay$100 in the stock at the end of FY21 → $21
Pay is from the Summary Compensation Table of each Entera Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Entera BioPublic company · 4 yr
    • Chief Finance Officer2022 – Present · 4 yrStock in role -2%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?